RK
Therapeutic Areas
Longeveron Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Laromestrocel (Lomecel-B™) | Alzheimer’s Disease | Phase 2 |
Leadership Team at Longeveron
SH
Stephen H. Willard
Chief Executive Officer
TP
Than Powell
Interim Chief Executive Officer, Vice President and Chief Business Officer
DJ
Dr. Joshua Hare
Co-founder, Chief Science Officer and Chairman
SK
Sunjay Kaushal, MD, PhD
Key Opinion Leader (Featured in KOL Event)